Synopsys (NASDAQ: SNPS) net income
Synopsys reported a net profit of $1,332m for fiscal 2025, 41.1% less than in fiscal 2024 ($2,263m). Its net margin was 18.9%. Earnings per share were $8.13.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $1,332m | −41.1% | 18.9% | $8.13 |
| 2024 | $2,263m | +84.0% | 36.9% | $14.78 |
| 2023 | $1,230m | +24.9% | 23.1% | $8.08 |
| 2022 | $984.6m | +30.0% | 21.3% | $6.44 |
| 2021 | $757.5m | +14.0% | 18.0% | $4.96 |
| 2020 | $664.3m | +24.8% | 18.0% | $4.40 |
| 2019 | $532.4m | +23.1% | 15.8% | $3.55 |
| 2018 | $432.5m | +216.7% | 13.9% | $2.90 |
| 2017 | $136.6m | −48.8% | 5.0% | $0.91 |
| 2016 | $266.8m | — | 11.0% | $1.76 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the net income of Synopsys
- How much did Synopsys earn in fiscal 2025?
- Synopsys reported a net profit of $1,332m for fiscal 2025. In fiscal 2024 it reported a net profit of $2,263m.
- What are the earnings per share of Synopsys?
- They were $8.13 in fiscal 2025, compared with $14.78 in fiscal 2024.
- What is the net margin of Synopsys?
- In fiscal 2025 its net profit was 18.9% of its revenue.
- What was the most profitable year for Synopsys?
- Of its last 10 fiscal years, fiscal 2024, with $2,263m.
- Where do the figures for Synopsys come from?
- From the annual report (Form 10-K) that Synopsys files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Synopsys files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Synopsys: the Synopsys page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.